MONTANUCCI, Pia
 Distribuzione geografica
Continente #
NA - Nord America 2.865
EU - Europa 1.702
AS - Asia 1.590
SA - Sud America 287
Continente sconosciuto - Info sul continente non disponibili 200
AF - Africa 34
OC - Oceania 2
Totale 6.680
Nazione #
US - Stati Uniti d'America 2.783
SG - Singapore 751
IT - Italia 289
IE - Irlanda 287
CN - Cina 240
BR - Brasile 220
HK - Hong Kong 206
RU - Federazione Russa 201
UA - Ucraina 195
FR - Francia 165
DE - Germania 146
VN - Vietnam 137
SE - Svezia 102
GB - Regno Unito 86
FI - Finlandia 79
IN - India 49
CA - Canada 42
KR - Corea 40
AT - Austria 39
BD - Bangladesh 27
TR - Turchia 24
IQ - Iraq 19
AR - Argentina 18
PL - Polonia 18
JP - Giappone 17
NL - Olanda 17
MX - Messico 16
ES - Italia 15
ZA - Sudafrica 15
CO - Colombia 14
EC - Ecuador 14
BE - Belgio 13
CZ - Repubblica Ceca 13
SA - Arabia Saudita 10
UZ - Uzbekistan 10
ID - Indonesia 9
CH - Svizzera 8
PY - Paraguay 8
PK - Pakistan 7
MY - Malesia 6
PH - Filippine 6
CL - Cile 5
ET - Etiopia 5
LB - Libano 5
CR - Costa Rica 4
GR - Grecia 4
HN - Honduras 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
EU - Europa 3
JO - Giordania 3
KE - Kenya 3
LT - Lituania 3
MA - Marocco 3
PS - Palestinian Territory 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
GE - Georgia 2
GP - Guadalupe 2
GT - Guatemala 2
IR - Iran 2
JM - Giamaica 2
LV - Lettonia 2
NO - Norvegia 2
OM - Oman 2
PR - Porto Rico 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BZ - Belize 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MK - Macedonia 1
MV - Maldive 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
SC - Seychelles 1
Totale 6.480
Città #
Singapore 542
Chandler 323
Ashburn 301
Dublin 287
San Jose 257
Hong Kong 204
San Mateo 142
Jacksonville 114
Perugia 102
Boardman 90
Santa Clara 90
Council Bluffs 88
Moscow 69
Ann Arbor 68
Princeton 68
Munich 66
Medford 63
Beijing 61
Altamura 56
Lauterbourg 54
Wilmington 48
Los Angeles 45
Dong Ket 42
Lawrence 41
Andover 40
Seoul 39
Ho Chi Minh City 34
Vienna 31
Des Moines 30
Redmond 30
New York 27
Dallas 25
São Paulo 24
The Dalles 23
Hanoi 22
Montreal 18
Piscataway 18
Houston 17
Helsinki 16
Phoenix 16
Warsaw 16
Tokyo 15
Turku 15
Atlanta 14
Orem 14
North Bergen 13
Norwalk 13
Saint Petersburg 13
Brussels 11
Chennai 11
Chicago 11
Johannesburg 11
London 11
Woodbridge 11
Denver 10
Izmir 10
Philadelphia 10
Rome 10
Stockholm 10
Baghdad 9
Boston 9
Manchester 9
Assisi 8
Auburn Hills 8
Falkenstein 8
Shanghai 8
Toronto 8
Milan 7
Rio de Janeiro 7
San Francisco 7
San Paolo di Civitate 7
Tashkent 7
Amsterdam 6
Basingstoke 6
Bogotá 6
Brooklyn 6
Buffalo 6
Haiphong 6
Manfredonia 6
Mumbai 6
Olomouc 6
Addis Ababa 5
Ankara 5
Belo Horizonte 5
Columbus 5
Den Haag 5
Dhaka 5
Frankfurt Am Main 5
Frankfurt am Main 5
Guarulhos 5
New Delhi 5
Poplar 5
Porto Alegre 5
Quito 5
Asunción 4
Brasília 4
Brno 4
Da Nang 4
Falls Church 4
Fremont 4
Totale 4.105
Nome #
Effects of streptozotocin on beta-cell precursor activatio in human islet derived cell monolayers 160
Microencapsulated G3C hybridoma cell graft delays the onset of spontaneous diabetes in NOD mice by an expansion of Gitr+ Treg cells 147
A comparison of lysosomal enzymes expression levels in peripheral blood of mild- and severe-Alzheimer’s disease and MCI patients: Implications for regenerative medicine approaches 146
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 141
Microencapsulation of cells and molecular therapy of type 1 diabetes mellitus: The actual state and future perspectives between promise and progress 140
MICROENCAPSULATED ISLET ALLOGRAFTS INTO NONIMMUNOSUPPRESSED PATIENTS WITH TYPE 1 DIABETES (TIDM) 137
Human Umbilical Cord Wharton Jelly-derived Adult Mesenchymal Stem Cells (hUCMS) in Microcapsules (CpS): A Novel Biohybrid System for Immunomodulation in T1D 136
In vivo HSV-1 T0Ahex gene transfer strategy for Tay-Sachs disease provides a wide distribution of B-Hexosaminidase A and restores the GM2 ganglioside metabolims in the brain animal model 135
Human Umbilical Cord Wharton Jelly-Derived Adult Mesenchymal Stem Cells, in Biohybrid Scaffolds, for Experimental Skin Regeneration 132
NMR analysis of non hydrolyzed samples of sodium alginate 129
Absence of metabolic cross-correction in Tay-Sachs cells: implication in gene therapy 129
Effects Of Streptozotocin On Beta-Cell Precursor Activation In Human Islet Derived Cell Monolayers. 129
Long-term cultured neonatal porcine islet cell monolayers: a potential tissue source for transplant in diabetes. 126
PRECURSORI BETA-CELLULARI IN COLTURE DI INSULE PANCREATICHE UMANE SOTTOPOSTE A STRESS IN VITRO 122
Brain-directed gene transfer therapy for Tay-Sachs disease gives rice a wider distribution of the B-Hexosaminidase A 118
Co-microencapsulation of human umbilical cord-derived mesenchymal stem and pancreatic islet-derived insulin producing cells in experimental type 1 diabetes 118
Effect of all trans retinoic acid on lysosomal alpha-D: -mannosidase activity in Hl-60 cell: correlation with Hl-60 cells differentiation 117
Design of a nanocomposite substrate inducing adult stem cell assembly and progression toward an Epiblast-like or Primitive Endoderm-like phenotype via mechanotransduction 117
EFFECTS OF POLI-L-LYSINE AND COLLAGEN ON FH-B-TPN CELL DIFFERENTIATION INTO ENDOCRINE CELL PHENOTYPE 116
Alpha and Beta subunits of b-N-acethyl-hexosaminidase are differently regulated during the mammalian brain development: implication for Tay-Sachs disease therapy 116
Microencapsulated Umbilical Cord Wharton Jelly-Derived Human Mesenchymal Stem Cells for the Cell Therapy of Type 1 Diabetes Mellitus (T1d): Applications and Limits 115
EFFECTS OF STRPTOZOTOCIN ON IN VITRO LONG TERM CULTURED HUMAN ISLETS CELLS MONOLAYERS 113
A8. 6 A novel therapeutic approach in systemic rheumatic autoimmune disorders: encapsulated human umbilical cord wharton jelly-derived mesenchymal stem cells 113
Study of the maternal-foetal interface in women with obesity and gestational diabetes as a potential mirror of foetal programming 112
Immunomodulatory effects of human umbelical cord Wharton jelly-derived mesenchymal stem cells (hUCMS) on circulating T-cell subsets in patients with Sjogren's syndrome 111
Reversal of Hyperglycemia by Microencapsulated Human Umbilical Cord Wharton Jelly-Derived Adult Mesenchymal Stem Cells (hUCMS) Graft (TX) in Spontaneously Nonobese Diabetic (NOD) Mice 109
Neonatal pig liver-derived progenitors for insulin-producing cells: an in vitro study 108
Long-term metabolic and immunological follow-up of nonimmunosuppressed patients with type 1 diabetes treated with microencapsulated islet allografts : four cases 107
Nano-engineered PLLA based biomaterial drives stem cell responses 106
Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. 104
ENGINEERED ALGINATE MICROCAPSULES FOR MOLECULAR THERAPY TROUGH BIOLOGIC SECRETING CELLS 104
Insights in Behavior of Variably Formulated Alginate-Based Microcapsules for Cell Transplantation 102
Restoration of the GM2 ganglioside metabolism in bone marrow-derived stromal cells from Tay-Sachs disease animal model 99
A9.18 Potential Therapeutic Application of Human Umbilical Cord wharton Jelly Derived Mesenchymal Stem Cells in Primary Sjogren's Syndrome 99
Remission of hyperglycemia in spontaneously diabetic NOD mice upon transplant of microencapsulated human umbilical cord Wharton jelly-derived mesenchymal stem cells (hUCMS) 99
Evidence for altered late endosomal-lysosomal compartment in Sandhoff fibroblasts 98
Utilization of a Commercial 3D Printer for the Construction of a Bio-Hybrid Device Based on Bioink and Adult Human Mesenchymal Cells 97
Direct brain gene transfer strategy for Tay-Sachs disease 97
Prevention of diabetes in NOD mice by increasing GITR positive Treg cells by low doses of anti-GITR antibody 96
Stem Cells for the Cell and Molecular Therapy of Type 1 Diabetes Mellitus (T1D) between Lights and Shadows 95
Xenotransplantation of microencapsulated human wharton jelly-derived adult mesenchymal stem cells (HUCMS) into overtly diabetic NOD mice 94
Surface Hydrophilicity of Poly(l-Lactide) Acid Polymer Film Changes the Human Adult Adipose Stem Cell Architecture 94
Emerging of a new CD3+CD31HCD184+ tang cell phenothype in Sjögren's syndrome induced by microencapsulated human umbilical cord matrix-derived multipotent stromal cells 92
Functional Profiles of Human Umbilical Cord-Derived Adult Mesenchymal Stem Cells in Obese/Diabetic Versus Healthy Women 92
Restoration of t cell substes of patients with type 1 diabetes mellitus by microencapsulated human umbilical cord wharton jelly-derived mesenchymal stem cells: An in vitro study 89
Microencapsulated Wharton Jelly-derived adult mesenchymal stem cells as a potential new therapeutic tool for patients with COVID-19 disease: an in vitro study 89
The functional performance of microencapsulated human pancreatic islet-derived precursor cells. 87
Treatment of diabetes mellitus with microencapsulated fetal human liver (FH-B-TPN) engineered cells 87
NMR analysis of sodium alginate 85
Directed hexa gene transfer therapy for Tay-Sachs disease provides a wide brain distribution of the B-Hexosaminidase a and restores the GM2 ganglioside metabolism 82
THERAPEUTIC APPLICATION OF HUMAN UMBILICAL CORD WHARTON JELLY-DERIVED MESENCHYMAL STEM CELLS (HUCMS) IN SYSTEMIC LUPUS ERYTHEMATOSUS: PITFALLS AND PERSPECTIVES 82
Immunomodulatory effects of human umbilical cord wharton jelly-derived mesenchymal stem cells (HUCMS) on circulating T-cell subsets in patients with sjögren’s syndrome 80
Clinical grade sodium alginate for microencapsulation of myofibroblasts isolated from wharton jelly for prevention and treatment of autoimmune and inflammatory diseases 79
In vivo gene transfer strategy for Tay-Sachs disease restores the GM2 ganglioside in the brain of the animal model 79
Molecular Characterization of Postpartum Umbilical Cord Wharton Jelly-derived Human Adult Mesenchymal Stem Cells (hUCMS) in Healthy vs. Obese/Diabetic Mothers 78
In Vitro Cultured Human Islet Cell Monolayers : Stemness Markers and Insulin Recovery upon Streptozotocin exposure. 76
New simple and rapid method for purification of mesenchymal stem cells from the human umbilical cord 76
Islet transplantation versus stem cells for the cell therapy of type 1 diabetes mellitus 72
Umbilical cord mesenchymal stem cells for the treatment of autoimmune diseases: Beware of cell-to-cell contact 72
Neonatal Pig Liver – Derived Undifferentiated Cells: A Potential New Source For Insulin Production 71
Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus. 71
Microencapsulation of Islets for the Treatment of Type 1 Diabetes Mellitus (T1D). 71
Stem cells for pancreatic β-cell replacement in diabetes mellitus 66
In vitro immunomodulatory effects of microencapsulated umbilical cord Wharton jelly-derived mesenchymal stem cells in primary Sjögren's syndrome. 64
ULTRAPURIFIED ALGINATE-BASED MICROCAPSULES FOR IMMUNOPROTECTION OF HUMAN ISLET ALLOGRAFTS IN TYPE 1 DIABETES MELLITUS 57
Totale 6.680
Categoria #
all - tutte 29.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022369 0 0 0 19 15 4 3 168 4 24 51 81
2022/20231.039 68 185 14 83 79 108 13 43 371 4 47 24
2023/2024413 33 38 23 8 2 4 134 10 25 12 61 63
2024/2025905 11 91 35 73 113 35 20 58 170 63 159 77
2025/20262.026 147 99 100 270 328 192 340 99 216 171 47 17
2026/2027643 37 56 125 425 0 0 0 0 0 0 0 0
Totale 6.680